BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26121935)

  • 1. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
    Li N; Pasricha S; Bulsiewicz WJ; Pruitt RE; Komanduri S; Wolfsen HC; Chmielewski GW; Corbett FS; Chang KJ; Shaheen NJ
    Dis Esophagus; 2016 Aug; 29(6):537-43. PubMed ID: 26121935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.
    Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
    Gastrointest Endosc; 2012 Oct; 76(4):733-9. PubMed ID: 22732872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
    Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
    Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
    Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett's esophagus with early neoplasia.
    Barret M; Belghazi K; Weusten BL; Bergman JJ; Pouw RE
    Gastrointest Endosc; 2016 Jul; 84(1):29-36. PubMed ID: 26769410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.
    Pasricha S; Cotton C; Hathorn KE; Li N; Bulsiewicz WJ; Wolf WA; Muthusamy VR; Komanduri S; Wolfsen HC; Pruitt RE; Ertan A; Chmielewski GW; Shaheen NJ
    Gastroenterology; 2015 Oct; 149(4):890-6.e2. PubMed ID: 26116806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus.
    Okoro NI; Tomizawa Y; Dunagan KT; Lutzke LS; Wang KK; Prasad GA
    Clin Gastroenterol Hepatol; 2012 Feb; 10(2):150-4. PubMed ID: 22056303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.
    Strauss AC; Agoston AT; Dulai PS; Srivastava A; Rothstein RI
    Surg Endosc; 2014 Dec; 28(12):3366-72. PubMed ID: 24950726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
    Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
    Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus.
    Bulsiewicz WJ; Kim HP; Dellon ES; Cotton CC; Pasricha S; Madanick RD; Spacek MB; Bream SE; Chen X; Orlando RC; Shaheen NJ
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):636-42. PubMed ID: 23103824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.
    Pasricha S; Li N; Bulsiewicz WJ; Rothstein RI; Infantolino A; Ertan A; Camara DS; Dellon ES; Triadafilopoulos G; Lightdale CJ; Madanick RD; Lyday WD; Muthusamy RV; Overholt BF; Shaheen NJ
    Gastrointest Endosc; 2015 Aug; 82(2):276-84. PubMed ID: 25841575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.
    Haidry RJ; Butt MA; Dunn JM; Gupta A; Lipman G; Smart HL; Bhandari P; Smith L; Willert R; Fullarton G; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Kapoor N; Hoare J; Narayanasamy R; Ang Y; Veitch A; Ragunath K; Novelli M; Lovat LB;
    Gut; 2015 Aug; 64(8):1192-9. PubMed ID: 25539672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of endoscopic submucosal dissection (ESD) plus radiofrequency ablation (RFA) for nodular Barrett's esophagus.
    Bahdi F; Katti CC; Mansour N; Gagneja H; Anandasabapathy S; Othman MO
    Scand J Gastroenterol; 2023 Feb; 58(2):123-132. PubMed ID: 35968576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex early Barrett's neoplasia at 3 Western centers: European Barrett's Endoscopic Submucosal Dissection Trial (E-BEST).
    Subramaniam S; Chedgy F; Longcroft-Wheaton G; Kandiah K; Maselli R; Seewald S; Repici A; Bhandari P
    Gastrointest Endosc; 2017 Oct; 86(4):608-618. PubMed ID: 28159540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.